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Prevalence and Antimicrobial Agent
Susceptibility of Methicillin-resistant
Staphylococcus aureus in Healthy Pediatric
Outpatients in Las Vegas
Echezona E. Ezeanolue, M.D.,
Mark P. Buttner, Ph.D., Patricia Cruz, Ph.D.,
Joanne L. Henry, B.S., Chad L. Cross, Ph.D.,
Linda D. Stetzenbach, Ph.D.
Abstract
Colonization and infection by communityassociated resistant strains of Staphylococcus aureus
are being reported in epidemic proportions. The
purpose of this study was to determine the local
prevalence of methicillin-resistant Staphylococcus
aureus (MRSA) colonization in children and to
characterize the MRSA isolates in the laboratory with
regard to antimicrobial agent susceptibility patterns,
and the presence of the mecA and the PantonValentine leukocidin (PVL) genes. Nasal swabs
were collected at two pediatric clinics from a total of
505 children during health maintenance visits. A
brief questionnaire was administered to collect
demographic data and pertinent medical, family, and
social history. Samples were cultured onto 2
selective media for S. aureus and MRSA. Potential
MRSA isolates were further evaluated by real-time
polymerase chain reaction (PCR), and for
susceptibility to eight antibiotics by disk diffusion.
Culture results showed that MRSA was present in 15
of the 505 specimens (3.0%). Six different
antimicrobial susceptibility profiles were observed
among the MRSA isolates. PCR amplification
results showed that all 15 MRSA isolates were
positive for the presence of the mecA gene, and 10
MRSA isolates contained the PVL gene.
Understanding local prevalence rates and the role of
colonization in infection are needed to develop
effective interventions to reduce MRSA infections
Key words: community-associated MRSA,
methicillin-resistant Staphylococcus aureus, nasal
carriage, pediatric
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Colonization and infection by community-associated
resistant strains of Staphylococcus aureus are being
reported in epidemic proportions in many areas of the
United States and around the world (Creech II,
Kernodle, Alsentzer, Wilson, & Edwards, 2005).
Although more frequently associated with skin and
soft tissue infections, community-associated
methicillin-resistant Staphylococcus aureus (CAMRSA) has been implicated in invasive infections in
children, with wide geographical diversity in rates of
colonization and infection (Hussain, Boyle-Vavra, &
Daum, 2001; Kaplan et al., 2005; Kuehnert et al.,
2005).
The increasing rate of MRSA infections has led
many clinicians to utilize newer staphylococcal
antimicrobial agents such as linezolid, as first line
empiric therapy. While some studies report equal
efficacy or superiority of linezolid to vancomycin in
treatment of MRSA (Sharpe, Shively, & Polk Jr.,
2005; Shorr, Kunkel, & Kollef, 2005), there are
reports of increasing clindamycin and rifampin
resistance among methicillin-resistant
Staphylococcus aureus and of unstable vancomycin
heteroresistance among clinical isolates of MRSA
(Plipat, Livni, Bertram, & Thompson, 2005; Tosun et
al., 2005). The two most important considerations in
choosing empiric antibiotic therapy are the
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knowledge of the most likely pathogen and the most
likely active agent. With the increasing prevalence of
MRSA, the large geographical diversity in
colonization and infection rates, and the presence of
increasing resistance to available therapies, clinicians
should be aware of their local resistance rates.
One method of gaining this knowledge is to
maintain inpatient and outpatient surveillance
programs, and to identify local colonization rates and
their relationship to clinical infections as well as
antimicrobial resistance patterns. The anterior nares
are the primary reservoir of Staphylococcus aureus in
adults and children (Casewell, 1998; Kluytmans, van
Belkum, & Verbrugh, 1997) with approximately onethird of the general population colonized at any given
time (Kluytmans, van Belkum, & Verbrugh, 1997).
Nasal carriage is a significant risk factor for
staphylococcal infection (Davis, Stewart, Crouch,
Florez, & Hospenthal, 2004; Kluytmans, van
Belkum, & Verbrugh, 1997), with >80% of infecting
isolates originating from the nose (vonEiff, Becker,
Machka, Stammer, & Peters, 2001; Wertheim et al.,
2004). In addition, eradication of nasal carriage often
eliminates the organism from other body sites (Parras
et al., 1995; Reagan et al., 1991).
The purpose of this study was to determine the
local prevalence of MRSA nasal colonization in
children. Isolates were also characterized with regard
to: 1) the presence of the mecA gene, encoding the
altered penicillin binding protein responsible for
[beta]-lactam resistance; 2) antimicrobial
susceptibility patterns; and 3) the presence of a
specific virulence factor gene, Panton-Valentine
leukocidin (PVL) (Baggett et al., 2004; Deurenberg
et al., 2004; Hsu et al., 2004). This information will
help in the development of recommendations for
selecting antimicrobial therapy, and is the first step in
maintaining a comprehensive pediatric database of
the antimicrobial susceptibility of infection-causing
microorganisms for Las Vegas, Nevada hospitals.
Materials and Methods
Study Design
The purpose of this study was to determine the
prevalence of MRSA in healthy children aged 2
weeks to 21 years. Age ranges in this study are
defined as infants (birth–2 years), adolescents (12–17
years), and young adults (18–21 years). Nasal swabs
were collected from 505 children during health
maintenance visits at two sites, Kids Health Pediatric
Clinic and Lied Clinic of the University Medical
Center in Las Vegas, Nevada. A brief questionnaire
was administered by the pediatric staff to each child
or responsible adult to collect demographic data and
pertinent medical, family and social history.
Specimens were cultured onto two selective media
for the isolation of S. aureus and MRSA. Swabs

were then enriched and subcultured onto selective
media after 24 hours of incubation. Real-time
polymerase chain reaction (PCR) was used to analyze
MRSA isolates for the presence of mecA and PVL
genes. The Kirby-Bauer disk diffusion method was
used to further characterize isolates based on their
susceptibility to eight antimicrobial agents. Data
were analyzed statistically to determine MRSA
prevalence rates and geospatial representation of
MRSA-positivity in Clark County.
Test Organisms and Culture Media
Four bacterial reference strains were used in this
study, including Escherichia coli ATCC 25922, S.
aureus ATCC 25923 (a methicillin-sensitive strain),
S. aureus ATCC 43300 (a MRSA strain), and S.
epidermidis ATCC 12228 (American Type Culture
Collection, Manassas, VA). All media were obtained
from BD Diagnostics, Sparks, MD, and included
BBL™ CHROMagar™ Staph aureus, BBL™
CHROMagar™ MRSA, Mueller Hinton II agar,
Difco™ tryptic soy agar, Trypticase™ soy agar with
5% sheep blood, and Trypticase™ soy broth with
6.5% sodium chloride (enrichment broth). All
cultures were incubated at 35°C for 24–48 hours.
Specimen Collection and Processing
Collection techniques and laboratory methods
were modeled after the previous work of Nakamura
(Nakamura et al., 2002). Specimens were collected
by pediatric staff with a dry, sterile swab (BBL
CultureSwab; BD Diagnostics) which was inserted
into each nostril of each subject, rotated for 5
seconds, and placed into a tube of liquid Stuart
transport medium (BD Diagnostics). Specimens
were refrigerated overnight, transported to the
laboratory the following morning, and processed
immediately upon arrival. Swabs were streaked for
isolation onto CHROMagar™ Staph aureus and
CHROMagar™ MRSA, placed in enrichment broth,
then vortexed for 10 seconds. All agar plate media
were incubated at 35°C for 24 hours. The enrichment
broth cultures were shaken at 130 rpm for 24 hours in
a 35°C environmental shaker incubator. The results
were recorded and CHROMagar™ MRSA plates
without typical MRSA colonies were incubated for
an additional 24 hours. The enrichment broth was
subcultured onto CHROMagar™ Staph aureus and
CHROMagar™ MRSA and streaked for isolation;
plates were incubated at 35°C for 24 hours. After
recording the results, the negative CHROMagar™
MRSA plates were incubated for another 24 hours.
Media performance characteristics were obtained
from the manufacturer’s package inserts. Mauve to
orange/mauve colonies produced on CHROMagar™
Staph aureus medium were identified as S. aureus
isolates. Smooth, moderately sized mauve colonies
which appeared on CHROMagar™ MRSA medium
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at 24 hours were interpreted as MRSA isolates.
Mauve colonies appearing at 48 hours and those with
atypical growth rates or colony morphology were
confirmed with further testing. These isolates were
subcultured to Trypticase™ soy agar with 5% sheep
blood, incubated for 24 hours, and then tested for
coagulase activity (ASI Staphslide Latex Test;
Arlington Scientific, Inc., Springville, UT) according
to the manufacturer’s instructions. All presumptive
MRSA isolates were Gram stained and then stored at
–70°C for use in additional testing.
Antimicrobial Susceptibility Testing
Antimicrobial susceptibility testing was
performed by Kirby-Bauer disk diffusion (direct
method) on Mueller Hinton medium according to
Clinical and Laboratory Standards Institute (Wayne,
PA) standards and included the following
antimicrobial agents: clindamycin (2 μg),
erythromycin (15 μg), gentamicin (10 μg), linezolid
(30 μg), mupirocin (5 μg), rifampin (5 μg),
trimethoprim-sulfamethoxazole (1.25 μg/23.75 μg),
and vancomycin (30 μg). All antimicrobial agents
were obtained from Becton Dickinson, except
mupirocin, which was obtained from Mast
Diagnostics, Merseyside, UK. Organisms included in
testing for quality control purposes were S. aureus
ATCC 25923 and E. coli ATCC 25922. Presumptive
MRSA isolates were subcultured onto tryptic soy
agar and incubated for 24 hours. Each bacterial
suspension was prepared according to the
antimicrobial agents manufacturers’ instructions by
inoculating 5 ml of Bacto™ tryptic soy broth (BD
Diagnostics) with a few isolated colonies and diluting
the suspension as needed to obtain turbidity
equivalent to a 0.5 McFarland standard (Wanger,
2007). Within 15 minutes of preparation, a sterile
cotton swab was dipped into the suspension; excess
liquid was expressed from the swab. The agar
surface was inoculated three times, rotating the plate
60° each time, then sweeping the swab around the
outer rim of the agar. The plates were allowed to dry
for 3–5 minutes before applying the disks. Four
disks were placed manually onto each plate with
sterile forceps and pressed firmly onto the surface.
To detect inducible clindamycin resistance, double
disk diffusion testing (D test) was performed by
placing the clindamycin and erythromycin disks 15
mm apart (center to center); all other disks were
placed 30 mm apart (Fiebelkorn, Crawford,
McElmeel, & Jorgensen, 2003; Frank et al., 2002).
Plates were incubated aerobically at 35°C for 16–18
hours. Zone diameters were measured to the nearest
millimeter and results were recorded as susceptible,
intermediate, or resistant based on interpretive
criteria provided by the antimicrobial agents
manufacturers.

DNA Extraction and Purification
Several colonies from each MRSA isolate were
suspended in 0.5 ml 0.01 M potassium phosphate
buffer with 0.05% Tween 20 (Sigma-Aldrich Co., St.
Louis, MO) (pH 7.0). DNA extraction and
purification from all test and control cultures were
performed using previously published protocols
(Buttner et al., 2004). Briefly, each suspension was
pretreated with sodium dodecyl sulfate and
proteinase K, incubated at 50°C, then boiled and
chilled on ice. Bovine serum albumin was added,
followed by incubation at 37°C in a rotary shaker.
The DNA from all isolates was purified by using the
Pellet Paint protocol (Novagen, Madison, WI).
Pellets were air dried overnight, then resuspended in
50 μl of Tris-EDTA buffer (pH 8.0) and stored at –
70°C.
Polymerase Chain Reaction
A real-time PCR assay utilizing the TaqMan®
(Applied Biosystems, Foster City, CA) technology
was used to detect the mecA gene (Francois et al.,
2003). The 7900 HT Fast Real-Time PCR System
(Applied Biosystems) was used for PCR analysis.
All primers were obtained from Operon Technologies
(Huntsville, AL) and the probes were obtained from
Applied Biosystems. Presumptive isolates were
analyzed using the oligonucleotide primers and probe
specified previously (Francois et al., 2003). The
mecA primer sequences (5 to 3 ) were as follows:
cattgatcgcaacgttcaattt (forward) and
tggtctttctgcattcctgga (reverse). The TaqMan® probe
sequence was 6-FAM-tggaagttagattgggatcatagcgtcatTAMRA. The reaction conditions included: 5 μl
genomic DNA, 1X TaqMan® Universal PCR Master
Mix (Applied Biosystems), 100 nM of each primer,
and 75 nM of probe. The reaction volume was
adjusted to 25 μl with nuclease-free water (Promega
Corp., Madison, WI). The TaqMan® amplification
conditions in Standard mode were 2 min at 50°C, 10
min at 95°C, and 40 cycles of 15 sec at 95°C
followed by 1 min at 60°C. Isolates were further
analyzed for the PVL gene by real-time PCR with the
use of oligonucleotide primers and probe sequences
as described previously (Deurenberg et al., 2004).
The PVL primer sequences (5 to 3 ) were:
gctggacaaaacttcttggaatat (forward) and
gataggacaccaataaattctggattg (reverse). The
TaqMan® probe sequence was 6-FAMaaaatgccagtgttatcca-MGBNFQ. The reaction
conditions included 5 μl genomic DNA, 1X
TaqMan® Universal PCR Master Mix, 0.6 μM of
each primer, and 175 nM MGB probe. The reaction
volume was adjusted to 25 μl with nuclease-free
water. The amplification conditions were as
described above. All MRSA isolates were amplified
in duplicate, and negative and positive controls were
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included with each PCR assay. DNA for both mecA
and PVL genes was assayed both undiluted and
diluted 10-fold. In addition, a 100-fold dilution was
assayed for the PVL gene. After amplification, the
data were analyzed and plotted (fluorescence vs.
cycle number) using the software provided with the
7900 PCR System. The extent of amplification was
reported by the software as the mean CT value of two
replicates. CT refers to the PCR cycle number where
detectable amplification product is measured, and is
inversely proportional to the initial DNA template
concentration.
Statistical Methods and Analyses
The number of study participants was
determined based on the population of 20,000
patients between the ages of 2 and 21 years that
utilize the two clinics (14,000 at the Lied Clinic of
the University Medical Center, and 6,000 at the Kids
Health Pediatric Clinic). An estimated MRSA
colonization rate of 2.4% (a three fold increase from
the average national rate of 0.8%) and a
hypergeometric distribution (sampling without
replacement – i.e., patients sampled only once
throughout the study) were utilized. This resulted in
an estimate that 475 participants were needed to
provide a population MRSA colonization prevalence
rate with 95% confidence and a power of 0.80 (alpha
= 0.05; Fisher exact test method). Descriptive and
inferential statistics were calculated for all variables
using SPSS version 15.0, SAS version 9.1, and
NCSS/PASS 2004.
Results
Culture Analysis
A total of 505 nasal swabs were obtained from
the two pediatric clinics. Results of culture analysis
showed that 15 of the 505 specimens (3.0%) were
positive for the presence of MRSA. Ten positive
specimens were obtained from the Kids Health
Pediatric Clinic and five positive specimens were
obtained from the Lied Clinic of the University
Medical Center. Of the MRSA positive specimens, 5
were obtained 24 hours after direct inoculation onto
CHROMagarTM MRSA, 1 was obtained 48 hours
after direct inoculation, and 9 were obtained after
enrichment for 24 hours. Incubation of the plated
enrichment broth for 48 hours yielded no additional
positive results. Although mauve colonies appeared
on 13 of the enriched specimens at 48 hours, these
were ruled out as potential MRSA by negative
coagulase tests.
S. aureus was isolated with CHROMagarTM
Staph aureus in a total of 177 of 505 specimens
(35.0%). The prevalence of MRSA among S. aureus
isolates was 8.5%. Of the positive S. aureus
specimens, 115 were obtained by direct inoculation
and 62 were detected only after enrichment. For 2

specimens in which positive results were obtained by
direct inoculation (1 and 2 CFU, respectively),
enrichment results were negative. All positive
MRSA specimens obtained with CHROMagarTM
MRSA were also positive for S. aureus on
CHROMagarTM Staph aureus.
Questionnaire Data
A total of 498 questionnaires were obtained with
the 505 specimens. All positive MRSA specimens
were accompanied by completed questionnaires. The
number of respondents between categories varied due
to incomplete or missing information obtained for
some questions. Basic summary statistics from the
questionnaire responses from patients showed a
median age of 4.9 and 1.9 years of age for Kids
Health Pediatric Clinic (N = 230) and Lied Clinic (N
= 251), respectively. Combined demographics for
both clinics showed that 4.3% (21/488) of the
participants had lived in a group home in the past
year, 5.0% (25/498) had a household member
working in a hospital or clinic, and 1.2% (6/498) had
a household member working in a correctional
facility. The medical history of the participants from
both clinics revealed that 68 of 490 (13.9%) had a
history of chronic illness, 86 of 488 (17.6%) had been
hospitalized, and 24 of 408 (5.9%) had been admitted
to the intensive care unit of a hospital. The antibiotic
use history of the participants indicated that 219 of
478 (45.8%) had been treated with antibiotics, 136 of
409 (33.3%) in the past year, and 42 of 405 (10.4%)
in the last month. Questionnaire responses from
adolescents and young adults (ages 12–21), revealed
that 1 in 65 (1.5%) had used intravenous illegal drugs
or done skin popping, 3 in 66 (4.5%) had tattoos, and
2 in 60 (3.3%) had been in jail or juvenile detention.
Analysis of the questionnaire data from families
with children colonized by MRSA showed a median
age of 3.2 and 0.6 years of age for Kids Health
Pediatric Clinic and Lied Clinic, respectively (Table
1). Combined demographics for both clinics showed
that of 15 patients, one had lived in a group home in
the past year, 3 had a household member working in
a hospital or clinic, and 1 had a household member
working in a correctional facility (Table 1).
Table 1. Demographics of MRSA positive patients
seen at Kids Health Pediatric Clinic and Lied Clinic,
Las Vegas, NV as reported on the study questionnaire
by each child or responsible adult (S.D. = standard
deviation).
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Variable
Age
(yrs)

Clinic
Kids
Health
Lied
Clinic

Total
People
in Home

Kids
Health
Lied
Clinic

Variable

Category

Gender

Female
Male

City

North Las
Vegas
Henderson
Las Vegas

School

Daycare
Elementary
Middle/High
None

N

Mean

SD

Median

Minimum

Maximum

9

5.0

5.56

3.2

0.5

15.4

5

4.6

7.09

0.6

0.3

16.8

9

5.4

2.24

5.0

2.0

9.0

5

5.8

1.92

6.0

3.0

8.0

Kids Health (N = 10)
Frequency
Percent
2
20.0
8
80.0

Has participant lived in
group home in past year?
Does any member of the
participant’s household
work in a hospital/clinic?
Does any member of the
participant’s household
work in a chronic care
facility?
Does any member of the
participant’s household
work in a school?
Does any member of the
participant’s household
work in a daycare?
Does any member of the
participant’s household
work in a correctional
facility?
Does any member of the
participant’s household
work in a home/school for
disabled persons?

30.0

1

20.0

1
6

10.0
60.0

0
4

0.0
80.0

1
1
2
6

10.0
10.0
20.0
60.0

1
0
1
3

20.0
0.0
20.0
60.0

Kids Health

Question

N
10

No
10
(100%)

Question
N

Lied Clinic (N = 5)
Frequency
Percent
3
60.0
2
40.0

3

Yes

N

0(0%)

5

Lied Clinic
No
4
(80%)

Yes
1
(20%)

10

7
(70%)

3
(30%)

5

5
(100%)

0
(0%)

10

10
(100%)

0
(0%)

5

5
(100%)

0
(0%)

10

7
(70%)

3
(30%)

5

4
(80%)

1
(20%)

10

10
(100%)

0
(0%)

5

5
(100%)

0
(0%)

10

10
(100%)

0
(0%)

5

4
(80%)

1
(20%)

10

10
(100%)

0
(0%)

5

5
(100%)

0
(0%)

The medical history indicated that 5 of the 15
children had been hospitalized (Table 2). The
antibiotic use history of these children indicated that
10 of 15 (66.7%) had been treated with antibiotics, 9
of 13 (69.2%) in the past year, and 4 of 12 (33.3%) in
the last month (Table 3). Questionnaire responses
from MRSA positive adolescents and young adults
(N = 4) revealed that one had used intravenous illegal
drugs or done skin popping, and had been in jail or
juvenile detention (Table 4).
Table 2. Medical history of MRSA positive patients
seen at Kids Health Pediatric Clinic and Lied Clinic,
Las Vegas, NV as reported on the study questionnaire
by each child or responsible adult (NICU = neonatal
intensive care unit).
Question
Does the participant
have a history of
chronic illness?
Has the participant
been hospitalized?
Does any member
of the participant’s
household have a
history of chronic
illness?
If an infant, did s/he
spend a prolonged
time in a nursery or
NICU?

N

Kids Health
No
Yes

N

Table 3. Antibiotic use history of MRSA positive
patients seen at Kids Health Pediatric Clinic and Lied
Clinic, Las Vegas, NV as reported on the study
questionnaire by each child or responsible adult.

Lied Clinic
No
Yes

Has the participant
ever been treated
with antibiotics?
Has the participant
been treated with
antibiotics in the past
year?
Has the participant
been treated with
antibiotics in the last
month?
Has any member of
the participant’s
household used
antibiotics?
Has any member of
the participant’s
household been
treated with
antibiotics in the past
year?
Has any member of
the participant’s
household been
treated with
antibiotics in the last
month?

N

Lied Clinic
No
Yes

10

3
(30%)

7
(70%)

5

2
(40%)

3
(60%)

9

3
(33%)

6
(67%)

4

1
(25%)

3
(75%)

8

5
(62%)

3
(38%)

4

3
(75%)

1
(25%)

0

0
(0%)

0
(0%)

0

0
(0%)

0
(0%)

9

3
(33%)

6
(67%)

4

2
(50%)

2
(50%)

9

5
(56%)

4
(44%)

5

5
(100%)

0
(0%)

Table 4. MRSA positive adolescent and young adult
(12–21 year-old) basic summary statistics from Kids
Health Pediatric Clinic and Lied Clinic, Las Vegas,
NV as reported on the study questionnaire by each
child or responsible adult (IV = intravenous).
Question
Do you smoke
cigarettes?
Have you ever used
IV illegal drugs or
done skin popping?
Do you have
tattoos?
Do you have pierced
ears?
Do you have
piercings in any
other parts of your
body?

10

9
(90%)

1
(10%)

5

4
(80%)

1
(20%)

10

7
(70%)

3
(30%)

5

3
(60%)

2
(40%)

Do you work?

10

9
(90%)

1
(10%)

5

4
(80%)

1
(20%)

Do you have a
boyfriend/girlfriend?
Have you ever been
in juvenile detention
or jail?

2
(100%)

0
(0%)

1

1
(100%)

0
(0%)

2

Kids Health
No
Yes

N
3
3
3
3

2

3
3
1

Kids Health
Lied Clinic
No
Yes
N
No
Yes
3
0
1
0
1
(100%)
(0%)
(100%)
(0%)
3
(100%)

0
(0%)

3
(100%)
1
(33%)

0
(0%)
2
(67%)

2
(100%)

0
(0%)

3
(100%)
3
(100%)

0
(0%)
0
(0%)

1
(100%)

0
(0%)

1
1
1

1

1
1
1

0
(0%)

1
(100%)

1
(100%)
1
(100%)

0
(0%)
0
(0%)

1
(100%)

0
(0%)

1
(100%)
1
(100%)

0
(0%)
0
(0%)

0
(0%)

1
(100%)
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Antimicrobial Susceptibility Testing
Six different antimicrobial agent susceptibility
profiles were observed from the MRSA isolates
(Table 5). Four of the isolates were susceptible to all
eight antimicrobial agents tested. Conversely, one
isolate was resistant to four antimicrobial agents.
Resistance to erythromycin was most frequent,
followed by clindamycin resistance. Inducible
clindamycin resistance due to erythromycin was
observed for two isolates.
Table 5. Antimicrobial agent susceptibility results
obtained for MRSA positive specimens. E. coli
ATCC 25922 and S. aureus ATCC 25923 were used
as QC organisms. Antimicrobial agent susceptibility
[susceptible (S), intermediate (I), and resistant (R)]
was determined with the Zone Diameter for
Staphylococcus spp. Interpretive Standards (CC =
Clindamycin, 2 μg; E = Erythromycin, 15 μg; GM =
Gentamicin, 10 μg; LZD = Linezolid, 30 μg; RA =
Rifampin, 5 μg; SXT = Trimethoprim/
Sulfamethoxazole, 1.25 μg/23.75 μg; Va =
Vancomycin, 30 μg; MUP = Mupirocin, 5 μg).
Antimicrobial Agent

Specimen
CC

E

GM

LZD

RA

SXT

Va

MUP

0085

S

S

S

S

S

S

S

S

0086

S

S

S

S

S

S

S

S

0111

R

R

S

S

S

S

S

S

0124

R

R

R

S

S

R

S

S

0141

R

R

S

S

S

S

S

S

0143

R

R

S

S

S

S

S

S

0185

S

R

S

S

S

S

S

S

0203

S

R

S

S

S

S

S

S

0204

S

R

S

S

S

S

S

S

0234

Ra

R

S

S

S

S

S

S

L084

S

R

S

S

S

S

S

S

L143

S

S

S

S

S

S

S

S

L157

S

R

S

S

S

S

S

S

L226

Ia

R

S

S

S

S

S

S

L039

S

S

S

S

S

S

S

S

a

D-zone effect observed between clindamycin and erythromycin

Polymerase Chain Reaction Analysis
PCR results are summarized in Table 6. All
MRSA isolates were confirmed by positive
amplification results for the presence of the mecA
gene. Ten of the fifteen MRSA isolates contained the
PVL gene, including all five isolates obtained from
children who had been hospitalized. Dilutions of the
DNA were performed for all samples, and sometimes
produced a stronger amplification result (lower cycle
threshold value, CT), indicating that partial PCR

inhibition occurred due to high concentrations of
DNA in the specimen (data not shown).
Table 6. PCR results obtained for the amplification
of MRSA isolates. Targets consisted of the PVL and
mecA genes. Plus (+) signs represent positive
amplification, and minus (–) signs represent no
amplification. Two replicates were amplified for
each DNA sample (ATCC = American Type Culture
Collection).
Microorganism
QC Organism
Escherichia
coli ATCC 25922
Staphylococcus
aureus ATCC 25923
S. aureus
ATCC 43300a
S. epidermidis
ATCC 12228
Specimen Id. #
0085
0086
0111
0124
0141
0143
0185
0203
0204
0234
L039
L084
L143
L157
L226
a

QPCR Results
PVL gene
mecA gene
–

–

+

–

–

+

–

–

+
+
–
–
–
–
+
+
+
+
+
+
+
+
–

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

MRSA strain
Discussion
Studies on MRSA colonization in healthy
pediatric populations have indicated nasal carriage
rates ranging from 0.2 to 2.5% (Cheng Immergluck et
al., 2004; Hussain, Boyle-Vavra, & Daum, 2001;
Kuehnert et al., 2006; Mainous III, Hueston, Everett,
& Diaz, 2006; Nakamura et al., 2002; Shopsin et al.,
2000). The MRSA colonization prevalence of 3.0%
measured for children in this study lies outside this
range and is considerably greater than the estimate of
0.6% (1–19 year age group) obtained in a nationwide
survey conducted in 2001–2002 (Kuehnert et al.,
2006). Because colonization typically precedes
infection, it is probable that the epidemic of MRSA
infections is a result of increasing colonization rates
in the population nationwide. Two studies conducted
in Nashville, Tennessee in 2001 and 2004 showed
that the colonization rate in children had increased
from 0.8% to 9.2% in three years (Creech II,
Kernodle, Alsentzer, Wilson, & Edwards, 2005;
Nakamura et al., 2002). Although this is the first
known survey of MRSA colonization of healthy
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children in Las Vegas, the results support the premise
that MRSA colonization rates are increasing. While
the number of MRSA specimens was relatively
small, the sample size was sufficiently large to
estimate the population prevalence rate with 95%
confidence. However, the small number of positives
precludes any further comparisons of questionnaire
data other than descriptive ones. S. aureus was
present in 35.0% of the specimens, similar to the
estimate of 36.9% (1–19 year age group) obtained in
the nationwide survey (Kuehnert et al., 2006), and to
the prevalence of 36.4% observed in Nashville
children in 2004 (Creech II, Kernodle, Alsentzer,
Wilson, & Edwards, 2005).
The presence of the mecA gene is considered an
indicator of methicillin resistance in Staphylococcus
aureus (Francois et al., 2003), and all of the positive
results obtained with the selective medium,
CHROMagarTM MRSA, were confirmed by positive
PCR results for the mecA gene. Previous research
has indicated that CHROMagarTM MRSA has high
specificity and sensitivity for the detection of MRSA
(Flayhart et al., 2005; Perry et al., 2004). The data
obtained from this survey showed that the enrichment
step in the culture protocol could improve the
detection of MRSA, as 9 of the 15 MRSA isolates
were detected by this step. Of the 6 MRSA isolates
detected by direct inoculation, 5 were isolated after
24 hours of incubation and 1 was determined after 48
hours. Because the enrichment broth step amplifies
those potential pathogens in numbers too low to
recover by routine culture techniques, it is a
procedure that individual laboratories can choose to
perform to enhance the detection of MRSA,
especially in low prevalence populations. However,
the disadvantages of the enrichment broth step are the
increase in the time delay to the determination of a
negative result, and increased costs. Therefore, this
optional procedure may be considered by
laboratorians depending upon their individual
circumstances.
MRSA infections that are acquired by persons
who have not been recently hospitalized or have had
a medical procedure are termed CA-MRSA
infections. On the basis of questionnaire data, 10 of
the 15 isolates in this study appear to be CA-MRSA.
Further molecular typing is needed to characterize the
MRSA strains isolated in this study and determine
whether they are consistent with healthcareassociated or CA-MRSA. The mecA gene is located
on a mobile genetic element, SCCmec
(staphylococcal cassette chromosome mec)
(Katayama et al., 2003). There are several different
SCCmec elements that have been characterized, with
CA-MRSA strains typically carrying the Type IV
SCCmec element (Huang et al., 2006; Moroney,

Heller, Arbuckle, Talavera, & Widen, 2007). The
PVL gene is associated with virulence and was
initially thought to be a characteristic of CA-MRSA
strains. However, one study showed that the PVL
gene was present in only 9.3% of MRSA isolates
containing the type IV SCCmec (Francois et al.,
2004). In this study, the PVL gene was present in all
5 apparent healthcare-associated MRSA isolates.
The frequency of occurrence of the PVL gene was
high among MRSA isolates in this study (66.7%)
compared with the nationwide survey in which 8% of
MRSA isolates contained the gene (Kuehnert et al.,
2005), and the 22% frequency observed in another
study (Creech II, Kernodle, Alsentzer, Wilson, &
Edwards, 2005). One of the limitations of this study
was that the MRSA isolates were not fully
characterized according to SCCmec strain types.
However, that was not a stated objective of this initial
survey.
Four of the MRSA isolates were sensitive to all 8
antimicrobial agents tested. Resistance to
erythromycin was most prevalent (11 of 15),
followed by clindamycin (5 of 15). One isolate
demonstrated resistance to 4 antimicrobial agents.
These results have clinical implications for treatment
of MRSA infections. Physicians treating pediatric
patients with skin and soft tissue infections should
consider use of empiric antimicrobial agents with
broad spectrum against MRSA until more
susceptibility data are available for developing
recommendations for antimicrobial therapy.
Additional monitoring and research are needed to
provide a more comprehensive estimate of the
prevalence and types of MRSA occurring in the local
pediatric population. Expanded surveillance utilizing
strain typing will permit tracking of MRSA isolates
in community acquired and nosocomial infections.
This will provide information that can be used to
minimize transmission and reduce the incidence of
MRSA in children in Las Vegas.
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